Making Undruggable Targets a Thing of the Past

  • 4th April, 2024
  • Podcasts
  • External Writer

Jen Nwankwo, CEO of 1910 Genetics, sits down with Amar Drawid to discuss her company’s approach to AI drug discovery, how it is seeking to address big challenges that plague the industry, and why the company is agnostic to drug modality.

Listen and watch the full podcast here.